# A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants

> **NCT01964872** · PHASE1 · COMPLETED · sponsor: **Janssen Cilag N.V./S.A.** · enrollment: 84 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** JNJ-38877618: Part 1a
- **DRUG:** JNJ-38877618: Part 1b
- **DRUG:** JNJ-38877618: Part 1c (optional)
- **DRUG:** JNJ-38877618: Part 2
- **DRUG:** JNJ-38877618: Part 3
- **DRUG:** JNJ-38877618: Part 4 (optional)
- **DRUG:** Placebo: Parts 1a, 2, 3, and 4 (optional)

## Key facts

- **NCT ID:** NCT01964872
- **Lead sponsor:** Janssen Cilag N.V./S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2014-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964872, "A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01964872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*